UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 7, 2015
Hercules Technology Growth Capital, Inc.
(Exact name of registrant as specified in its charter)
Maryland | 814-00702 | 74-3113410 | ||
(State or other jurisdiction of incorporation) |
(Commission File No.) |
(I.R.S. Employer Identification No.) |
400 Hamilton Ave., Suite 310 Palo Alto, CA |
94301 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (650) 289-3060
Not Applicable
(Former name or address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
Election of Dr. Rodney A. Ferguson, Ph.D
On July 7, 2015, the Board of Directors of Hercules Technology Growth Capital, Inc. (the Company) elected Dr. Rodney A. Ferguson, Ph.D. as a director of the Company. In connection with his election, the Board of Directors increased the size of the Board of Directors to seven directors. There are no arrangements or understandings between Dr. Ferguson and any other persons pursuant to which Dr. Ferguson was elected as a director of the Company. Dr. Ferguson also will be entitled to enter into an indemnification agreement with the Company. Dr. Ferguson will be entitled to applicable retainer and meeting fees and an option award and restricted stock award pursuant to the Companys director compensation arrangements, under terms consistent with those disclosed below.
Dr. Ferguson joined the Company as a director in July 2015 and will hold office as a class III director for a term expiring in 2016. He will serve on the Compensation Committee of the Board of Directors.
Dr. Ferguson is a co-founder of Panorama Capital, a venture capital firm which spun off from JPMorgan Partners (JPMP) in July 2006, where he focuses primarily on life sciences investments. Prior to that, from 2001 to 2006,he was a Managing Director at JPMP in their life sciences venture practice. From 1999 to 2001, Dr. Ferguson was a partner at InterWest Partners (InterWest), a venture capital firm, where he focused on life sciences investments. Prior to InterWest, he held a variety of management positions over an 11-year career at Genentech, Inc., most recently as Senior Director of Business and Corporate Development responsible for worldwide licensing transactions for both technology and pharmaceutical products. Prior to joining Genentech, Inc. in 1988, Dr. Ferguson was an associate with the law firm McCutchen, Doyle, Brown, & Enersen from 1984 to 1988.
Dr. Ferguson has served on the technology advisory board of The Economist since 2004. Dr. Ferguson has served on the boards of directors of Itero BioPharmaceuticals, Inc. and CardioKinetix, Inc. since 2008 and on the board of directors of Alvine Pharmaceuticals, Inc. since 2013. Dr. Ferguson also serves as chairman of the board of InnVision Shelter Network, a non-profit organization, and has been a member of its board of directors since 2008. Dr. Ferguson received a B.S. with honors in Biochemistry from the University of Illinois, a Ph.D. in Biochemistry from the State University of New York at Buffalo, and a J.D. cum laude from Northwestern University.
Director Compensation
On July 7, 2015, the Companys Board of Directors voted to revise its compensation arrangements. In connection therewith, each of the Companys independent directors is entitled to an annual retainer of $100,000 for Board service. The Chairs of the Audit and Compensation Committees, respectively, are entitled to receive an annual retainer of $25,000 for such service and the Chair of the Nominating and Corporate Governance Committee is entitled to receive an annual retainer of $15,000. In addition, the Companys Lead Independent Director is entitled to receive an annual retainer of $25,000.
Consistent with the Companys prior practice, upon re-election to the Board of Directors, each continuing independent director will continue to be granted an option to purchase 15,000 shares and an additional award of 5,000 shares of restricted stock. Upon appointment to the Board of Directors, new independent directors will continue to receive a restricted stock award with respect to 3,333 shares of the Companys common stock and a stock option to purchase 10,000 shares of the Companys common stock.
Employee directors and non-independent directors do not receive compensation for serving on the Companys board. In addition, the Company reimburses its directors for their reasonable out-of-pocket expenses incurred in attending board meetings.
Departure of Chief Credit Officer
On July 13, 2015, Robert C. Lake announced his resignation from his position as the Companys Chief Credit Officer due to family reasons.
Item 5.05 Amendments to the Registrants Code of Ethics, or Waiver of a Provision of the Code of Ethics
On July 7, 2015, the Board of Directors amended the Companys Code of Business Conduct and Ethics (the Code) to more closely conform to the language and regulations of the New York Stock Exchange.
The description of the amendments to the Code contained in this report is qualified in its entirety by reference to the full text of the Code, filed as Exhibit 14 to this Current Report on Form 8-K. The Code, as amended, is available in the Corporate Governance section of the Companys website at www.herculestech.com
Item 8.01 | Other Events. |
The Company issued a press release on July 13, 2015, which is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits
14.1 | Code of Business Conduct and Ethics | |
99.1 | Press Release dated July 13, 2015 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
HERCULES TECHNOLOGY GROWTH CAPITAL, INC. | ||||||
July 13, 2015 | By: |
/s/ Andrew Olson |
||||
Andrew Olson | ||||||
Chief Financial Officer |
EXHIBIT INDEX
Exhibit
No. |
Description of Exhibits |
|
14.1 | Code of Business Conduct and Ethics | |
99.1 | Press Release dated July 13, 2015 |
Exhibit 14.1
CODE OF BUSINESS CONDUCT AND ETHICS
Adopted: July 7, 2015
CODE OF BUSINESS CONDUCT AND ETHICS
TABLE OF CONTENTS
Adopted: July 7, 2015 |
i | |||
Section I. Introduction |
1 | |||
Section II. Purpose of the Code |
1 | |||
Section III. Conflicts of Interest |
1 | |||
Section IV. Corporate Opportunities |
3 | |||
Section V. Confidentiality |
3 | |||
Section VI. Fair Dealing |
3 | |||
Section VII. Protection and Proper Use of Company Assets |
3 | |||
Section VIII. Compliance with Applicable Laws, Rules and Regulations |
4 | |||
Section IX. Equal Opportunity, Harassment |
4 | |||
Section X. Records Related to Litigation |
5 | |||
Section XI. Outside Employment |
5 | |||
Section XII. Service as a Director |
5 | |||
Section XIII. Dealings with Government and Industry Regulators |
5 | |||
Section XIV. Media Relations |
6 | |||
Section XV. Intellectual Property Information |
6 | |||
Section XVI. Internet and E-Mail Policy |
6 | |||
Section XVII. Reporting Violations and Complaint Handling |
6 | |||
Section XVIII. Sanctions for Code Violations |
8 | |||
Section XIX. Application/Waivers |
8 | |||
Section XX. Revisions and Amendments |
8 | |||
Section XXI. Other Policies and Procedures |
8 | |||
Section XXII. Internal Use |
8 | |||
APPENDIX A |
||||
Acknowledgment Regarding Code of Business Conduct and Ethics |
A-1 |
Section I. Introduction
This Code of Business Conduct and Ethics (the Code ) has been adopted by Hercules Technology Growth Capital, Inc. (the Company ) in order to establish applicable policies, guidelines, and procedures that promote ethical practices and conduct by the Company and all its employees, officers, and directors. You should carefully read and retain a copy of the Code for future reference. The Code is primarily designed to assist you in the recognition and resolution of potential conflicts of interest, maintain the confidentiality of our business activities, assist in the compliance with all applicable securities laws and reporting of any unethical or illegal conduct, and reaffirm and promote the Companys commitment to a corporate culture that values honesty, integrity, and accountability.
All officers, directors and employees ( Covered Persons ) of the Company are responsible for maintaining this level of integrity and for complying with the policies contained in this Code. If you have a question or concern about what is proper conduct for you or anyone else, please raise these concerns with the Chief Compliance Officer or any member of the Companys senior management, or follow the procedures outlined in applicable sections of this Code.
The Companys Code of Ethics under Rule 17j-1 under the Investment Company Act of 1940, as amended (the 1940 Act ) and the Companys Insider Trading Policy, contain separate requirements for persons covered by this Code and other persons and is not part of this Code.
Section II. Purpose of the Code
This Code is intended to:
1. | help you recognize ethical issues and take the appropriate steps to resolve these issues; |
2. | deter ethical violations to avoid any abuse of position of trust and responsibility; |
3. | maintain confidentiality of our business activities; |
4. | assist you in complying with applicable securities laws; |
5. | assist you in reporting any unethical or illegal conduct; and |
6. | reaffirm and promote our commitment to a corporate culture that values honesty, integrity and accountability. |
As a condition of employment or continued employment, you must acknowledge annually, in writing, that you have received a copy of this Code, read it, and understand that the Code contains our expectations regarding your conduct. You also will receive any updates and updated versions of this Code and will be required to read and acknowledge such updates.
Section III. Conflicts of Interest
You must avoid any conflict, or the appearance of a conflict, between your personal interests and the Companys interests. A conflict of interest occurs when your private interests interfere in any way, or even appears to interfere, with the interests of, or your service to, the Company. For example, a conflict of interest probably exists if:
1. | you, or a member of your family, receives improper personal benefits as a result of the Covered Persons position with the Company; |
2. | you use any non-public information about us, our customers, or our other business partners for your personal gain, or the gain of a member of your family; |
3. | you use or communicate confidential information obtained in the course of your work for your or anothers personal benefit; or |
4. | you take actions or have interests that may make it difficult to perform your work on behalf of the Company objectively and effectively. |
Certain conflicts of interest arise out of the relationships between Covered Persons and the Company and already are subject to conflict of interest provisions in the 1940 Act. For example, Covered Persons may not individually engage in certain transactions with the Company because of their status as affiliated persons of the Company.
Other conflicts of interest are covered by the Code, even if such conflicts of interest are not subject to provisions in the 1940 Act. The following list provides examples of conflicts of interest under the Code, but Covered Persons should keep in mind that these examples are not exhaustive. The overarching principle is that the personal interest of a Covered Person should not be placed before the interest of the Company, unless the personal interest has been disclosed to and approved by the Audit Committee.
Each Covered Person must:
1. | not use his or her personal influence or personal relationships improperly to influence investment decisions or financial reporting by the Company whereby the Covered Person would benefit personally to the detriment of the Company; |
2. | not cause the Company to take action, or fail to take action, for the individual personal benefit of the Covered Person rather than benefit the Company; |
3. | not use material non-public knowledge of portfolio transactions made or contemplated for the Company to trade personally or cause others to trade personally in contemplation of the market effect of such transactions; and |
4. | complete any Director or Officer Questionnaire provided by the Company. |
There are some conflict of interest situations that should always be subject to approval by the Audit Committee if material. Examples of these include:
1. | service as a director on the board of any company; |
2. | the receipt of any non-nominal gifts valued in excess of $100; |
3. | the receipt of any entertainment from any company with which the Company has current or prospective business dealings unless such entertainment is business-related, reasonable in cost, appropriate as to time and place, and not so frequent as to raise any question of impropriety; |
4. | any ownership interest in, or any consulting or employment relationship with, any of the Companys service providers; and |
5. | a direct or indirect financial interest in commissions, transaction charges or spreads paid by the Company for effecting portfolio transactions or for selling shares other than an interest arising from the Covered Persons employment, such as compensation or equity ownership. |
2
Section IV. Corporate Opportunities
Each of us has a duty to advance the legitimate interests of the Company when the opportunity to do so presents itself. Therefore, you may not:
1. | take for yourself personally opportunities, including investment opportunities, discovered through the use of your position with us, or through the use of Company property or information; |
2. | use our property, information, or position for your personal gain or the gain of a family member; or |
3. | compete, or prepare to compete, with us. |
Section V. Confidentiality
You must not disclose confidential information regarding us, our affiliates, our lenders, or our other business partners, unless disclosure is authorized or required by law. Confidential information includes all non-public information that might be harmful to, or useful to the competitors of, the Company, our affiliates, our lenders or our other business partners. Even after you leave the Company, this obligation continues until the information becomes publicly available.
All reports and records prepared or maintained pursuant to this Code will be considered confidential and will be maintained and protected accordingly. Except as otherwise required by law or this Code, such matters will not be disclosed by the Company to anyone other than the Board of Directors and its counsel.
Section VI. Fair Dealing
You must endeavor to deal fairly with our suppliers and business partners, or any other companies or individuals with whom we do business or come into contact with, including fellow employees and our competitors. You must not take unfair advantage of these or other parties by means of:
1. | manipulation; |
2. | concealment; |
3. | abuse of privileged information; |
4. | misrepresentation of material facts; or |
5. | any other unfair-dealing practice. |
Section VII. Protection and Proper Use of Company Assets
Our assets are to be used only for legitimate business purposes. Theft, carelessness and waste have a direct impact on the Companys profitability. You should protect our assets and ensure that they are used efficiently.
3
Incidental personal use of telephones, fax machines, copy machines, personal computers and similar equipment is generally allowed if there is no significant added cost to us, it does not interfere with your work duties, it is in compliance with the Companys policy with respect to internet usage and social media and is not related to an illegal activity or to any outside business.
Section VIII. Compliance with Applicable Laws, Rules and Regulations
Each of us has a duty to comply with all laws, rules and regulations that apply to our business. Highlighted below are some of the key compliance guidelines that must be followed.
1. | Insider trading. It is against the law to buy or sell securities using material information that is not available to the public. Individuals who give this inside information to others may be liable to the same extent as the individuals who trade while in possession of such information. You must not trade in our securities, or the securities of our affiliates, our lenders, or our other business partners while in the possession of inside information. All employees are required to be familiar and comply with our Insider Trading Policy in the Companys Compliance Manual. |
2. | Whistleblower protections. It is against the law to discharge, demote, suspend, threaten, harass, or discriminate in any manner against an employee who provides information or otherwise assists in investigations or proceedings relating to violations of federal securities laws or other federal laws prohibiting fraud against shareholders. You must not discriminate in any way against an employee who engages in these whistleblower activities. You are encouraged to refer to our Whistleblower Policy in the Companys Compliance Manual. |
3. | 1940 Act requirements. A separate code of ethics has been established to comply with Rule 17j-1 under the 1940 Act and is applicable to those persons designated in such code. |
4. | Document retention. You must adhere to appropriate procedures governing the retention and destruction of records consistent with applicable laws, regulations and our policies. You may not destroy, alter or falsify any document that may be relevant to a threatened or pending lawsuit or governmental investigation. All employees are required to be familiar and comply with our Recordkeeping Policy in the Companys Compliance Manual. |
Please talk to the Chief Compliance Officer or any member of senior management if you have any questions about how to comply with the above regulations and other laws, rules and regulations.
In addition, we expect you to comply with all our policies and procedures that apply to you. We may modify or update our policies and procedures in the future, and may adopt new Company policies and procedures from time to time. You are also expected to observe the terms of any confidentiality agreement, employment agreement or other similar agreement that applies to you.
Section IX. Equal Opportunity, Harassment
We are committed to providing equal opportunity in all of our employment practices including selection, hiring, promotion, transfer, and compensation of all qualified applicants and employees without regard to race, color, sex or gender, sexual orientation, religion, age, national origin, handicap, disability, citizenship status, or any other status protected by law. With this in mind, there are certain behaviors that will not be tolerated. These include harassment, violence, intimidation, and discrimination of any kind involving race, color, sex or gender, sexual orientation, religion, age, national origin, handicap, disability, citizenship status, marital status, or any other status protected by law.
4
Section X. Records Related to Litigation
The law requires us to maintain certain types of corporate records, usually for specified periods of time. Failure to retain those records for those minimum periods could subject us to penalties and fines, cause the loss of rights, obstruct justice, place us in contempt of court, or seriously disadvantage us in litigation If we inform you, or you believe that our records are relevant to any litigation or governmental action, or any potential litigation or action, then you must preserve those records until we determine the records are no longer required to be preserved. This requirement supersedes any previously or subsequently established destruction policies for those records. If you believe that this requirement may apply, or have any questions regarding the possible applicability of this requirement, please contact our Chief Compliance Officer.
Section XI. Outside Employment
Without the written consent of the Chief Executive Officer, no officer or employee is permitted to:
1. | engage in any other financial services business; |
2. | be employed or compensated by any other business for work performed; or |
3. | have a significant (more than 5% equity) interest in any other financial services business, including, but not limited to, banks, brokerages, investment advisers, insurance companies or any other similar business. |
Requests for outside employment waivers must be made in writing to the Chief Executive Officer with a copy to the Chief Compliance Officer of the Company.
Section XII. Service as a Director
No officer or employee may serve as a director or officer of any organization, other than the Company, without prior written authorization from our Chief Compliance Officer. Any request to serve on the board or as an officer of such an organization must include the name of the entity and its business, the names of the other board members or officers, as applicable, and a general reason for the request. The appropriate Chief Compliance Officer will consult with the Chief Executive Officer in connection with such request.
Section XIII. Dealings with Government and Industry Regulators
The Companys policy forbids payments of any kind by us, our employees or any agent or other intermediary to any government official, self-regulatory official or other similar person or entity, within the United States or abroad, for the purpose of obtaining or retaining business, or for the purpose of influencing favorable consideration of any application for a business activity or other matter. This policy covers all types of payments, even to minor government officials and industry regulators, regardless of whether the payment would be considered legal under the circumstances, provided that, subject to certain limitations, political contributions or donations of an amount less than the then federally-mandated maximum amount, made without the intent to obtain or retain business or favorably influence consideration of any application for a business activity or other matter, are permitted, as further explained below. Employees are required to avoid even the appearance of impropriety in their dealings with industry and government regulators and officials, even with respect to permissible contributions or donations.
5
It is expected and required that all employees fulfill their personal obligations to governmental and regulatory bodies. Those obligations include the filing of appropriate federal, state and local tax returns, as well as the filing of any applicable forms or reports required by regulatory bodies.
All employees are required to cooperate fully with management in connection with any internal or independent investigation and any claims, actions, arbitrations, litigations, investigations or inquiries brought by or against us. Employees are expected, if requested, to provide us with reasonable assistance, including, but not limited to, meeting or consulting with the Company and our representatives, reviewing documents, analyzing facts and appearing or testifying as witnesses or interviewees or otherwise.
Employees are required to immediately notify the appropriate Chief Compliance Officer in the event they are contacted by any national, state, local or self-regulatory authority or body regarding a potential or actual litigation, investigation, examination, or inquiry directly or indirectly involving the Company, unless, upon the written advice of legal counsel, such employee is prohibited by law from doing so in such case.
Section XIV. Media Relations
We must speak with a unified voice in all dealings with the press and other media. As a result, the Companys Chief Executive Officer, or his designee, is the sole contact for media seeking information about the Company. Any requests from the media regarding the Company must be referred to its Chief Executive Officer, or his designee.
Section XV. Intellectual Property Information
Information generated in our business is a valuable asset. Protecting this information plays an important role in our growth and ability to compete. Such information includes business and research plans; objectives and strategies; trade secrets; unpublished financial information; salary and benefits data; and lender and other business partner lists. Employees who have access to our intellectual property information are obligated to safeguard it from unauthorized access and:
1. | not disclose this information to persons outside of the Company; |
2. | not use this information for personal benefit or the benefit of persons outside of the Company; and |
3. | not share this information with other employees except on a legitimate need to know basis. |
Section XVI. Internet and E-Mail Policy
We provide an e-mail system and Internet access to certain of our employees to help them do their work. You may use the e-mail system and the Internet only for legitimate business purposes in the course of your duties. Incidental and occasional personal use is permitted, but never for personal gain or any improper or illegal use. Further, you are prohibited from discussing or posting information regarding the Company in any external electronic forum, including Internet chat rooms, electronic bulletin boards or social media sites. You are encouraged to refer to our Social Media Policy in the Companys Compliance Manual for more information.
Section XVII. Reporting Violations and Complaint Handling
You are responsible for compliance with the rules, standards and principles described in this Code. In addition, you should be alert to possible violations of the Code by the Companys employees,
6
officers and directors, and you are required to report a violation promptly. Normally, reports should be made to ones immediate supervisor. Under some circumstances, it may be impractical or you may feel uncomfortable raising a matter with your supervisor. In those instances, you are encouraged to contact the Chief Compliance Officer who will investigate the matter and potentially report it to the Companys Chief Executive Officer and/or Board of Directors, as the circumstance dictates. You will also be expected to cooperate in an investigation of a violation.
The Company has also adopted a Whistleblower Policy pursuant to which you may report a concern about our conduct, the conduct of a director, officer or employee of the Company or our accounting, internal accounting controls or auditing matters directly to the Audit Committee of the Board of Directors of the Company. All reported concerns will be reviewed and by the Audit Committee and/or by the Chief Compliance Officer on behalf of the Audit Committee. The status of all outstanding concerns forwarded to the Audit Committee will be reported on a quarterly basis by the Companys Chief Compliance Officer. The Audit Committee may direct that certain matters be presented to the full Board and may retain outside advisors or counsel, for any concern reported to it. You are encouraged to refer to our Whistleblower Policy in the Companys Compliance Manual and to report any concerns that you might have.
All reports will be investigated and, whenever possible, requests for confidentiality will be honored. And, while anonymous reports will be accepted, please understand that anonymity may hinder or impede the investigation of a report. All cases of questionable activity or improper actions will be reviewed for appropriate action, discipline or corrective actions. Whenever possible, we will keep confidential the identity of employees, officers or directors who are accused of violations, unless or until it has been determined that a violation has occurred.
There will be no reprisal, retaliation or adverse action taken against any employee who, in good faith, reports or assists in the investigation of, a violation or suspected violation, or who makes an inquiry about the appropriateness of an anticipated or actual course of action.
For reporting concerns about the Companys conduct, the conduct of a director, officer or employee of the Company, or about the Companys accounting, internal accounting controls or auditing matters, you may use the following means of communication:
1. By Mail: | Chief Compliance Officer | |
Hercules Technology Growth Capital, Inc. | ||
400 Hamilton Avenue, Suite 310 | ||
Palo Alto, CA 94301 | ||
2. Confidentially By Mail: | Chairperson of the Audit Committee | |
To be Opened by Audit Committee Only | ||
C/o Chief Compliance Officer | ||
Hercules Technology Growth Capital, Inc. | ||
400 Hamilton Avenue, Suite 310 | ||
Palo Alto, CA 94301 | ||
3. Anonymously By Phone to Ethics Hotline: | 1-650-433-5576 | |
4. By Email to Chief Compliance Officer: | complianceofficer@herculestech.com |
7
Section XVIII. Sanctions for Code Violations
All violations of the Code are subject to appropriate corrective action, up to and including dismissal. If the violation involves potentially criminal activity, the individual or individuals in question will be reported, as warranted, to the appropriate authorities.
Section XIX. Application/Waivers
All the directors, officers and employees of the Company are subject to this Code.
Any material amendment or waiver of the Code for an executive officer of the Company or a member of the Board of Directors of the Company must be made by the Board of Directors and disclosed on a Form 8-K filed with the SEC within four business days following such amendment or waiver.
Section XX. Revisions and Amendments
This Code may be revised, changed or amended at any time by our Board of Directors. Following any material revisions or updated, an updated version of this Code will be distributed to you, and will supersede the prior version of this Code effective upon distribution. We may ask you to sign an acknowledgement confirming that you have read and understood the revised version of the Code, and that you agree to comply with the provisions.
Section XXI. Other Policies and Procedures
This Code will be the sole code of business conduct and ethics adopted by the Company for purposes of Section 406 of the Sarbanes-Oxley Act and the rules and forms applicable to registered investment companies thereunder. Insofar as other policies or procedures of the Company may govern the behavior or activities of the Covered Person who are subject to this Code, they are superseded by this Code to the extent that they overlap or conflict with the provisions of this Code.
Section XXII. Internal Use
The Code is intended solely for the internal use by the Company and does not constitute an admission, by or on behalf of any Company, as to any fact, circumstance, or legal conclusion.
8
APPENDIX A
Hercules Technology Growth Capital, Inc.
Acknowledgment Regarding Code of Business Conduct and Ethics
This acknowledgment is to be signed and returned to the appropriate Chief Compliance Officer and will be retained as part of your permanent personnel file.
I have received a copy of Hercules Technology Growth Capital, Inc.s Code of Business Conduct and Ethics, read it, and understand that the Code contains the expectations regarding employee conduct. I agree to observe the policies and procedures contained in the Code of Business Conduct and Ethics and have been advised that, if I have any questions or concerns relating to such policies or procedures, I understand that I have an obligation to report to the Audit Committee, the Chief Compliance Officer or other such designated officer, any suspected violations of the Code of which I am aware. I also understand that the Code is issued for informational purposes and that it is not intended to create, nor does it represent, a contract of employment.
Employees Name (Printed) |
|
|||||
Employees Signature |
|
|||||
Date |
|
The failure to read and/or sign this acknowledgment in no way relieves you of your responsibility to comply with Hercules Technology Growth Capital, Inc.s Code of Business Conduct and Ethics.
A-1
Exhibit 99.1
Hercules Appoints Dr. Rodney A. Ferguson, Ph.D. to its Board of Directors
PALO ALTO, Calif., July 13, 2015 - Hercules Technology Growth Capital, Inc. (NYSE: HTGC), the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related industries, including technology, biotechnology, life sciences, and energy & renewable technology, at all stages of development, today announced that effective July 7, 2015, Dr. Rodney A. Ferguson, a life sciences veteran and co-founder of Panorama Capital, was appointed to the Hercules Board of Directors.
Dr. Ferguson will serve on Hercules Compensation Committee.
Dr. Ferguson is a co-founder of Panorama Capital, a venture capital firm which spun off from JPMorgan Partners (JPMP) in July 2006, where he focuses primarily on life sciences investments. Prior to that, from 2001 to 2006, he was a Managing Director at JPMP in their life sciences venture practice. From 1999 to 2001, Dr. Ferguson was a partner at InterWest Partners (InterWest), a venture capital firm, where he focused on life sciences investments. Before joining InterWest, he held a variety of management positions over an 11-year career at Genentech, Inc., most recently as Senior Director of Business and Corporate Development responsible for worldwide licensing transactions for both technology and pharmaceutical products. Prior to joining Genentech in 1988, Dr. Ferguson was an associate with the law firm McCutchen, Doyle, Brown, & Enersen from 1984 to 1988.
Dr. Ferguson has served on the technology advisory board of The Economist since 2004. Dr. Ferguson has served on the boards of directors of Itero BioPharmaceuticals, Inc. and CardioKinetix, Inc. since 2008 and on the board of directors of Alvine Pharmaceuticals, Inc. since 2013. Dr. Ferguson also serves as chairman of the board of InnVision Shelter Network, a non-profit organization, and has been a member of its board of directors since 2008. Dr. Ferguson received a Bachelor of Science degree with honors in Biochemistry from the University of Illinois, a Ph.D. in Biochemistry from the State University of New York at Buffalo, and a J.D. cum laude from Northwestern University.
About Hercules Technology Growth Capital, Inc.
Hercules Technology Growth Capital, Inc. (NYSE: HTGC) (Hercules) is the leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in technology-related industries, including technology, biotechnology, life sciences, and energy & renewable technology, at all stages of development. Since inception (December 2003), Hercules has committed more than $5.2 billion to over 320 companies and is the lender of choice for entrepreneurs and venture capital firms seeking growth capital financing. Companies interested in learning more about financing opportunities should contact info@htgc.com , or call 650.289.3060.
1
Hercules common stock trades on the New York Stock Exchange (NYSE) under the ticker symbol HTGC.
In addition, Hercules has three outstanding bond issuances of 7.00% Notes due April 2019, 7.00% Notes due September 2019, and 6.25% Notes due July 2024, which trade on the NYSE under the symbols HTGZ, HTGY, and HTGX, respectively.
Contact:
Michael Hara
Investor Relations and Corporate Communications
Hercules Technology Growth Capital, Inc.
650-289-3060 HT-HN
mhara@htgc.com
or
Muirfield Partners
Mickey Mandelbaum, 310-785-0810
mickey@muirfieldpartners.com
or
Muirfield Partners
Maya Pogoda, 310-785-0810
maya@muirfieldpartners.com
2